- |||||||||| Enrollment closed: Stroke Swallowing Screening Tool Validation (clinicaltrials.gov) - Oct 22, 2015
P=N/A, N=305, Active, not recruiting, Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- |||||||||| Trial completion, Enrollment change, Trial initiation date, Trial primary completion date: Transcranial Direct Current Stimulation for Dysphagia Therapy in Acute Stroke Patients (clinicaltrials.gov) - Oct 14, 2015
P=N/A, N=60, Completed, Enrolling by invitation --> Completed | Trial primary completion date: Dec 2015 --> Aug 2015 Recruiting --> Completed | N=100 --> 60 | Initiation date: Jan 2012 --> Jun 2012 | Trial primary completion date: Dec 2015 --> Dec 2014
- |||||||||| Trial completion, Enrollment change, Trial primary completion date: Study of Tongue Strengthening for Swallowing Problems (clinicaltrials.gov) - Oct 14, 2015
P=N/A, N=34, Completed, Active, not recruiting --> Completed | N=30 --> 14 Not yet recruiting --> Completed | N=100 --> 34 | Trial primary completion date: Mar 2014 --> Sep 2015
- |||||||||| Trial primary completion date: CoFAR5: Eosinophilic Esophagitis Databank (clinicaltrials.gov) - Oct 2, 2015
P=N/A, N=715, Recruiting, Active, not recruiting --> Completed Trial primary completion date: Jun 2015 --> Dec 2015
- |||||||||| Erbitux (cetuximab) / Eli Lilly, EMD Serono
Trial completion, Metastases: Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer (clinicaltrials.gov) - Sep 30, 2015 P1, N=43, Completed, Trial primary completion date: Jun 2015 --> Dec 2015 Active, not recruiting --> Completed
- |||||||||| montelukast / Generic mfg.
Trial completion, Enrollment change: Trial of Montelukast in Eosinophilic Esophagitis (clinicaltrials.gov) - Sep 25, 2015 P1, N=41, Completed, Active, not recruiting --> Completed Recruiting --> Completed | N=60 --> 41
- |||||||||| Enrollment status, Enrollment change: Gastroesophageal Reflux Treatment in Scleroderma (clinicaltrials.gov) - Sep 21, 2015
P3, N=80, Recruiting, Enrolling by invitation --> Completed Enrolling by invitation --> Recruiting | N=250 --> 80
- |||||||||| Enrollment open, Trial initiation date, Trial primary completion date: Swallowing and Breathing Exercises for Dysphagia in Parkinson Disease (clinicaltrials.gov) - Aug 29, 2015
P=N/A, N=100, Recruiting, Recruiting --> Completed | N=100 --> 79 | Trial primary completion date: Jun 2011 --> Mar 2013 Not yet recruiting --> Recruiting | Initiation date: Apr 2014 --> Nov 2013 | Trial primary completion date: Sep 2014 --> Apr 2016
- |||||||||| bupropion / Generic mfg.
Trial completion: Bupropion in Helping Adults Stop Smoking (clinicaltrials.gov) - Aug 28, 2015 P2, N=97, Completed, Not yet recruiting --> Recruiting | Initiation date: Apr 2014 --> Nov 2013 | Trial primary completion date: Sep 2014 --> Apr 2016 Active, not recruiting --> Completed
- |||||||||| Trial primary completion date: Esophageal Absorption in EoE (clinicaltrials.gov) - Aug 22, 2015
P=N/A, N=40, Recruiting, Active, not recruiting --> Completed Trial primary completion date: Sep 2015 --> Dec 2015
- |||||||||| omeprazole / Generic mfg.
Enrollment closed, Trial primary completion date: CYP2C19 Genotype Predictor of Gastric Acid Suppression (clinicaltrials.gov) - Aug 19, 2015 P0, N=100, Active, not recruiting, N=132 --> 60 | Trial primary completion date: Apr 2014 --> Feb 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2015 --> Dec 2016
- |||||||||| TheraCIM (nimotuzumab) / Daiichi Sankyo, Oncoscience, Biocon
Trial completion, Combination therapy, Metastases: Nimotuzumab in Combination With Chemoradiation for Esophageal Cancer (clinicaltrials.gov) - Aug 19, 2015 P1, N=11, Completed, Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2015 --> Dec 2016 Recruiting --> Completed
|